HLA-B27 and disease pathogenesis: New structural and functional insights

Expert Reviews in Molecular Medicine

Volumn 1, Issue 16, 1999, Pages 1-10

  Bowness, Paul ^a   Zaccai, Nathan ^b   Bird, Lucy ^a   Jones, E Yvonne ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ankylosing spondylitis; HC B27; HLA; HLA B27; HLA B27; homodimer; human leucocyte antigen; human leukocyte antigen; major histocompatibility antigen; MHC; spondylarthritis; spondyloarthritis

Indexed keywords

EID: 85012563989     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399499001118     Document Type: Article

References (45)

1. Brewerton, D.A. et al. (1973) Ankylosing spondylitis and HL-A 27. Lancet 1, 904–907, PubMed ID:73214579
2. Brown, M.A. et al. (1996) HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 55, 268–270, PubMed ID:96297335
3. Benjamin, R. and Parham, P. (1990) Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 11, 137–142, PubMed ID:90253570
4. Lahesmaa, R. et al. (1992) Molecular mimicry in the pathogenesis of spondyloarthropathies. A critical appraisal of cross-reactivity between microbial antigens and HLA-B27. Br J Rheumatol 31, 221–229, PubMed ID:92208647
5. Davenport, M.P. (1995) The promiscuous B27 hypothesis. Lancet 346, 500–501, PubMed ID:95364519
6. Marker-Hermann, E., Meyer zum Buschenfelde, K.H. and Wildner, G. (1997) HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis. Arthritis Rheum 40, 2047–2054, PubMed ID:98030377
7. Khare, S.D. et al. (1998) Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J Immunol 160, 101–106, PubMed ID:98211687
8. Townsend, A.R. et al. (1986) The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44, 959–968, PubMed ID:86161685
9. Madden, D.R. et al. (1991) The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353, 321–325, PubMed ID:92018187
10. Jardetzky, T.S. et al. (1991) Identification of self peptides bound to purified HLA-B27. Nature 353, 326–329, PubMed ID:92018188
11. Rotzschke, O. et al. (1994) Dominant aromatic/ aliphatic C-terminal anchor in HLA-B∗2702 and B∗2705 peptide motifs. Immunogenetics 39, 74–77, PubMed ID:94041470
12. Tanigaki, N. et al. (1994) The peptide binding specificity of HLA-B27 subtypes. Immunogenetics 40, 192–198, PubMed ID:94314367
13. Bowness, P., Allen, R.L. and McMichael, A.J. (1994) Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27. Eur J Immunol 24, 2357–2363, PubMed ID:95010249
14. Lopez de Castro, J.A. (1998) The pathogenetic role of HLA-B27 in chronic arthritis. Curr Opin Immunol 10, 59–66, PubMed ID:98183714
15. Lopez-Larrea, C. et al. (1995) HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 45, 169–176, PubMed ID:95282144
16. D'Amato, M. et al. (1995) Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 25, 3199–3201, PubMed ID:96085198
17. Fiorillo, M.T. et al. (1997) Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur J Immunol 27, 368–373, PubMed ID:97197610
18. Hammer, R.E. et al. (1990) Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63, 1099–1112, PubMed ID:91077923
19. Breban, M. et al. (1993) Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 178, 1607–1616, PubMed ID:94045447
20. Taurog, J.D. et al. (1993) Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 150, 4168–4178, PubMed ID:93232623
21. Breban, M. et al. (1996) T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 156, 794–803, PubMed ID:96133010
22. Khare, S.D., Luthra, H.S. and David, C.S. (1995) Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med 182, 1153–1158, PubMed ID:96018814
23. Khare, S.D. et al. (1996) HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest 98, 2746–2755, PubMed ID:97136519
24. Hermann, E. et al. (1993) HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342, 646–650, PubMed ID:93368296
25. Ugrinovic, S. et al. (1997) A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. J Immunol 159, 5715–5723, PubMed ID:98208296
26. Gaston, J.S. et al. (1996) Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. J Rheumatol 23, 130–136, PubMed ID:96435635
27. Benjamin, R.J., Madrigal, J.A. and Parham, P. (1991) Peptide binding to empty HLA-B27 molecules of viable human cells. Nature 351, 74–77, PubMed ID:91226541
28. Urban, R.G. et al. (1994) A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci U S A 91, 1534–1538, PubMed ID:94151364
29. Peh, C.A. et al. (1998) HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8, 531–542, PubMed ID:98281996
30. Whelan, M.A. and Archer, J.R. (1993) Chemical reactivity of an HLA-B27 thiol group. Eur J Immunol 23, 3278–3285, PubMed ID:94080894
31. Maclean, L., Hammer, R. and Taurog, J. (eds) (1997) Cytokine profiles and site-directed B27 mutation in the HLA-B27 transgenic rat. Proceedings of the 12th International Histocompatibility Workshop, EDK
32. MacLean, L. et al. (1992) Sulphydryl reactivity of the HLA-B27 epitope: accessibility of the free cysteine studied by flow cytometry. Ann Rheum Dis 51, 456–460, PubMed ID:92264822
33. Gao, X.M. et al. (1996) Homocysteine modification of HLA antigens and its immunological consequences. Eur J Immunol 26, 1443–1450, PubMed ID:96305398
34. Bowness, P. et al. (1998) Importance of a conserved TCR J alpha-encoded tyrosine for T cell recognition of an HLA B27/peptide complex. Eur J Immunol 28, 2704–2713, PubMed ID:98425529
35. Allen, R.L. et al. (1999) Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol 162, 5045–5048, PubMed ID:99244860
36. Stam, N.J., Spits, H. and Ploegh, H.L. (1986) Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137, 2299–2306, PubMed ID:87009876
37. Ellis, S.A., Taylor, C. and McMichael, A. (1982) Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol 5, 49–59, PubMed ID:83006626
38. Madden, D.R. et al. (1992) The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70, 1035–1048, PubMed ID:92405152
39. Garboczi, D.N. et al. (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134–141, PubMed ID:97064169
40. Lanier, L.L. (1998) Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 92, 705–707, PubMed ID:98188095
41. Zhou, M. et al. (1998) The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. J Exp Med 188, 877–886, PubMed ID:98401022
42. Esnouf, R.M. (1997) An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph Model 15, 132–134, 112–133, PubMed ID:98046670
43. Merritt, E.A. and Murphy, M.E.P. (1994) Raster 3D version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr A 50, 869–873
44. Jones, T.A. et al. (1991) Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47, 110–119, PubMed ID:91222453
45. Brunger, A.T. (1992) X-PLOR Manual. Yale University, New Haven, CT, USA